Sign in / Join Now
ETFs & Funds
Charts say don't buy the pop in Ligand Pharmaceuticals (
). Wait for a pullback.
Add a reply...
Latest StockTalks »
people get LGND breaking news and analysis by email alert.
Get email alerts on LGND »
Ligand Pharmaceuticals Incorporated
Get latest price
From other sites
Ligand Partner Melinta Therapeutics Submits Baxdela New Drug Application For Hospital-Treated Skin Infections
at TheStreet (Mon, 9:21AM)
Ligand Partner Lundbeck Receives FDA Approval Of Carnexiv™ (carbamazepine) Injection As Intravenous Short-Term Replacement Therapy For Certain Seizure Types
at TheStreet (Oct 7, 2016)
Ligand Pharmaceuticals Enters Oversold Territory (LGND)
at Nasdaq.com (Sep 27, 2016)
Ligand Licenses Four Programs To Seelos Therapeutics
at TheStreet (Sep 22, 2016)
Ligand Enters OmniAb® License Agreement With TeneoBio, Inc.
at TheStreet (Sep 16, 2016)